Loading…
Development and qualification of the parallel line model for the estimation of human influenza haemagglutinin content using the single radial immunodiffusion assay
Highlights ► We improve SRID for release of commercial inactivated influenza vaccines. ► Parallel line preferred to traditional slope ratio model. ► We develop and qualify HA quantification in cell culture-derived influenza vaccines. ► Robust and reproducible method with high precision and guarantee...
Saved in:
| Published in: | Vaccine 2012-01, Vol.30 (2), p.201-209 |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c526t-f3d21b6dee3f5906e2df80a4b70ddb030332e7707b0015d4489fa0ab6917bace3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c526t-f3d21b6dee3f5906e2df80a4b70ddb030332e7707b0015d4489fa0ab6917bace3 |
| container_end_page | 209 |
| container_issue | 2 |
| container_start_page | 201 |
| container_title | Vaccine |
| container_volume | 30 |
| creator | van Kessel, G Geels, M.J de Weerd, S Buijs, L.J de Bruijni, M.A.M Glansbeek, H.L van den Bosch, J.F Heldens, J.G van den Heuvel, E.R |
| description | Highlights ► We improve SRID for release of commercial inactivated influenza vaccines. ► Parallel line preferred to traditional slope ratio model. ► We develop and qualify HA quantification in cell culture-derived influenza vaccines. ► Robust and reproducible method with high precision and guaranteed long-term stability. |
| doi_str_mv | 10.1016/j.vaccine.2011.11.023 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_918055705</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X11017907</els_id><sourcerecordid>3217319371</sourcerecordid><originalsourceid>FETCH-LOGICAL-c526t-f3d21b6dee3f5906e2df80a4b70ddb030332e7707b0015d4489fa0ab6917bace3</originalsourceid><addsrcrecordid>eNqFks-KFDEQxhtR3HH1EZSAB08zVpLuTvdFkXX9AwseVPAW0kllJmM6me10D4yvsy9qemdcYS8LBSnIr76i6quieElhRYHWb7ervdLaBVwxoHSVAxh_VCxoI_iSVbR5XCyA1eWypPDrrHiW0hYAKk7bp8UZYxREU7aL4uYj7tHHXY9hJCoYcj0p76zTanQxkGjJuEGyU4PyHj3xuSHpo8mpjcPtH6bR9Xf0ZupVIC5YP2H4o8hGYa_Waz-NLrhAdAzj3GlKLqxvy-fEIxmUccoT1_dTiMZZm4msqFJSh-fFE6t8when97z4-enyx8WX5dW3z18vPlwtdcXqcWm5YbSrDSK3VQs1MmMbUGUnwJgOOHDOUAgQHQCtTFk2rVWgurqlolMa-Xnx5qi7G-L1lOeSvUsavVcB45RkSxuoKpGX-DDJRFsfydf3yG2chpDHkLRsBW85pzNVHSk9xJQGtHI35KUOB0lBznbLrTzZLWe7ZY5sd657dVKfuh7NXdU_fzPw_ghg3tve4SCTdhg0GjegHqWJ7sEW7-4p6HwE-T78bzxg-j-NTEyC_D7f3HxyNGuKFgT_CwfR1q8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1497393315</pqid></control><display><type>article</type><title>Development and qualification of the parallel line model for the estimation of human influenza haemagglutinin content using the single radial immunodiffusion assay</title><source>ScienceDirect Freedom Collection</source><creator>van Kessel, G ; Geels, M.J ; de Weerd, S ; Buijs, L.J ; de Bruijni, M.A.M ; Glansbeek, H.L ; van den Bosch, J.F ; Heldens, J.G ; van den Heuvel, E.R</creator><creatorcontrib>van Kessel, G ; Geels, M.J ; de Weerd, S ; Buijs, L.J ; de Bruijni, M.A.M ; Glansbeek, H.L ; van den Bosch, J.F ; Heldens, J.G ; van den Heuvel, E.R</creatorcontrib><description>Highlights ► We improve SRID for release of commercial inactivated influenza vaccines. ► Parallel line preferred to traditional slope ratio model. ► We develop and qualify HA quantification in cell culture-derived influenza vaccines. ► Robust and reproducible method with high precision and guaranteed long-term stability.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2011.11.023</identifier><identifier>PMID: 22107849</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Allergy and Immunology ; Chemistry Techniques, Analytical - methods ; Haemagglutinin quantification ; Hemagglutinin Glycoproteins, Influenza Virus - analysis ; Humans ; Influenza ; Influenza vaccine ; Influenza Vaccines - immunology ; Influenza Vaccines - standards ; Influenza virus ; Manufacturing ; Models, Statistical ; Pandemics ; Parallel line model ; Quality Control ; Reproducibility of Results ; Single Radial Immunodiffusion ; Technology, Pharmaceutical - standards ; Vaccines</subject><ispartof>Vaccine, 2012-01, Vol.30 (2), p.201-209</ispartof><rights>Elsevier Ltd</rights><rights>2011 Elsevier Ltd</rights><rights>Copyright © 2011 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Jan 5, 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c526t-f3d21b6dee3f5906e2df80a4b70ddb030332e7707b0015d4489fa0ab6917bace3</citedby><cites>FETCH-LOGICAL-c526t-f3d21b6dee3f5906e2df80a4b70ddb030332e7707b0015d4489fa0ab6917bace3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22107849$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Kessel, G</creatorcontrib><creatorcontrib>Geels, M.J</creatorcontrib><creatorcontrib>de Weerd, S</creatorcontrib><creatorcontrib>Buijs, L.J</creatorcontrib><creatorcontrib>de Bruijni, M.A.M</creatorcontrib><creatorcontrib>Glansbeek, H.L</creatorcontrib><creatorcontrib>van den Bosch, J.F</creatorcontrib><creatorcontrib>Heldens, J.G</creatorcontrib><creatorcontrib>van den Heuvel, E.R</creatorcontrib><title>Development and qualification of the parallel line model for the estimation of human influenza haemagglutinin content using the single radial immunodiffusion assay</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Highlights ► We improve SRID for release of commercial inactivated influenza vaccines. ► Parallel line preferred to traditional slope ratio model. ► We develop and qualify HA quantification in cell culture-derived influenza vaccines. ► Robust and reproducible method with high precision and guaranteed long-term stability.</description><subject>Allergy and Immunology</subject><subject>Chemistry Techniques, Analytical - methods</subject><subject>Haemagglutinin quantification</subject><subject>Hemagglutinin Glycoproteins, Influenza Virus - analysis</subject><subject>Humans</subject><subject>Influenza</subject><subject>Influenza vaccine</subject><subject>Influenza Vaccines - immunology</subject><subject>Influenza Vaccines - standards</subject><subject>Influenza virus</subject><subject>Manufacturing</subject><subject>Models, Statistical</subject><subject>Pandemics</subject><subject>Parallel line model</subject><subject>Quality Control</subject><subject>Reproducibility of Results</subject><subject>Single Radial Immunodiffusion</subject><subject>Technology, Pharmaceutical - standards</subject><subject>Vaccines</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqFks-KFDEQxhtR3HH1EZSAB08zVpLuTvdFkXX9AwseVPAW0kllJmM6me10D4yvsy9qemdcYS8LBSnIr76i6quieElhRYHWb7ervdLaBVwxoHSVAxh_VCxoI_iSVbR5XCyA1eWypPDrrHiW0hYAKk7bp8UZYxREU7aL4uYj7tHHXY9hJCoYcj0p76zTanQxkGjJuEGyU4PyHj3xuSHpo8mpjcPtH6bR9Xf0ZupVIC5YP2H4o8hGYa_Waz-NLrhAdAzj3GlKLqxvy-fEIxmUccoT1_dTiMZZm4msqFJSh-fFE6t8when97z4-enyx8WX5dW3z18vPlwtdcXqcWm5YbSrDSK3VQs1MmMbUGUnwJgOOHDOUAgQHQCtTFk2rVWgurqlolMa-Xnx5qi7G-L1lOeSvUsavVcB45RkSxuoKpGX-DDJRFsfydf3yG2chpDHkLRsBW85pzNVHSk9xJQGtHI35KUOB0lBznbLrTzZLWe7ZY5sd657dVKfuh7NXdU_fzPw_ghg3tve4SCTdhg0GjegHqWJ7sEW7-4p6HwE-T78bzxg-j-NTEyC_D7f3HxyNGuKFgT_CwfR1q8</recordid><startdate>20120105</startdate><enddate>20120105</enddate><creator>van Kessel, G</creator><creator>Geels, M.J</creator><creator>de Weerd, S</creator><creator>Buijs, L.J</creator><creator>de Bruijni, M.A.M</creator><creator>Glansbeek, H.L</creator><creator>van den Bosch, J.F</creator><creator>Heldens, J.G</creator><creator>van den Heuvel, E.R</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20120105</creationdate><title>Development and qualification of the parallel line model for the estimation of human influenza haemagglutinin content using the single radial immunodiffusion assay</title><author>van Kessel, G ; Geels, M.J ; de Weerd, S ; Buijs, L.J ; de Bruijni, M.A.M ; Glansbeek, H.L ; van den Bosch, J.F ; Heldens, J.G ; van den Heuvel, E.R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c526t-f3d21b6dee3f5906e2df80a4b70ddb030332e7707b0015d4489fa0ab6917bace3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Allergy and Immunology</topic><topic>Chemistry Techniques, Analytical - methods</topic><topic>Haemagglutinin quantification</topic><topic>Hemagglutinin Glycoproteins, Influenza Virus - analysis</topic><topic>Humans</topic><topic>Influenza</topic><topic>Influenza vaccine</topic><topic>Influenza Vaccines - immunology</topic><topic>Influenza Vaccines - standards</topic><topic>Influenza virus</topic><topic>Manufacturing</topic><topic>Models, Statistical</topic><topic>Pandemics</topic><topic>Parallel line model</topic><topic>Quality Control</topic><topic>Reproducibility of Results</topic><topic>Single Radial Immunodiffusion</topic><topic>Technology, Pharmaceutical - standards</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Kessel, G</creatorcontrib><creatorcontrib>Geels, M.J</creatorcontrib><creatorcontrib>de Weerd, S</creatorcontrib><creatorcontrib>Buijs, L.J</creatorcontrib><creatorcontrib>de Bruijni, M.A.M</creatorcontrib><creatorcontrib>Glansbeek, H.L</creatorcontrib><creatorcontrib>van den Bosch, J.F</creatorcontrib><creatorcontrib>Heldens, J.G</creatorcontrib><creatorcontrib>van den Heuvel, E.R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Biological Sciences</collection><collection>ProQuest Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest Healthcare Administration Database</collection><collection>PML(ProQuest Medical Library)</collection><collection>Proquest Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Kessel, G</au><au>Geels, M.J</au><au>de Weerd, S</au><au>Buijs, L.J</au><au>de Bruijni, M.A.M</au><au>Glansbeek, H.L</au><au>van den Bosch, J.F</au><au>Heldens, J.G</au><au>van den Heuvel, E.R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and qualification of the parallel line model for the estimation of human influenza haemagglutinin content using the single radial immunodiffusion assay</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2012-01-05</date><risdate>2012</risdate><volume>30</volume><issue>2</issue><spage>201</spage><epage>209</epage><pages>201-209</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>Highlights ► We improve SRID for release of commercial inactivated influenza vaccines. ► Parallel line preferred to traditional slope ratio model. ► We develop and qualify HA quantification in cell culture-derived influenza vaccines. ► Robust and reproducible method with high precision and guaranteed long-term stability.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>22107849</pmid><doi>10.1016/j.vaccine.2011.11.023</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2012-01, Vol.30 (2), p.201-209 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_918055705 |
| source | ScienceDirect Freedom Collection |
| subjects | Allergy and Immunology Chemistry Techniques, Analytical - methods Haemagglutinin quantification Hemagglutinin Glycoproteins, Influenza Virus - analysis Humans Influenza Influenza vaccine Influenza Vaccines - immunology Influenza Vaccines - standards Influenza virus Manufacturing Models, Statistical Pandemics Parallel line model Quality Control Reproducibility of Results Single Radial Immunodiffusion Technology, Pharmaceutical - standards Vaccines |
| title | Development and qualification of the parallel line model for the estimation of human influenza haemagglutinin content using the single radial immunodiffusion assay |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T06%3A45%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20qualification%20of%20the%20parallel%20line%20model%20for%20the%20estimation%20of%20human%20influenza%20haemagglutinin%20content%20using%20the%20single%20radial%20immunodiffusion%20assay&rft.jtitle=Vaccine&rft.au=van%20Kessel,%20G&rft.date=2012-01-05&rft.volume=30&rft.issue=2&rft.spage=201&rft.epage=209&rft.pages=201-209&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2011.11.023&rft_dat=%3Cproquest_cross%3E3217319371%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c526t-f3d21b6dee3f5906e2df80a4b70ddb030332e7707b0015d4489fa0ab6917bace3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1497393315&rft_id=info:pmid/22107849&rfr_iscdi=true |